Synergistic effects of brain injury and aging: common mechanisms of proteostatic dysfunction

Janani Saikumar1, Nancy M Bonini1

  • 1Department of Biology, University of Pennsylvania, Philadelphia, PA 19104, USA.

Insights

Traumatic brain injury (TBI) disrupts brain proteostasis, leading to accelerated aging and neurodegeneration. This review highlights how TBI impairs protein quality control, contributing to long-term cognitive decline and brain aging.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Gerontology

Background:

  • Traumatic brain injury (TBI) triggers acute stress and protein aggregate formation.
  • Subtle molecular changes post-TBI can lead to age-associated neurodegenerative disorders.
  • The exact molecular pathways driving unhealthy brain aging after TBI remain unclear.

Purpose of the Study:

  • To review proteostatic dysfunction as a unifying mechanism in accelerated brain aging following TBI.
  • To synthesize evidence from human tissues and animal models concerning TBI, aging, and proteostasis.
  • To elucidate the link between TBI-induced proteostatic impairment and subsequent aging hallmarks.

Main Methods:

  • Review of existing literature on TBI, brain aging, and proteostasis.
  • Examination of human tissue studies.
  • Analysis of in vivo animal models investigating injury and aging contexts.

Main Results:

  • TBI induces a sustained negative impact on the brain's proteostatic machinery.
  • Proteostatic dysfunction is identified as a key factor in unhealthy brain aging post-TBI.
  • Evidence supports a link between TBI and the exacerbation of pathological and cognitive aging features.

Conclusions:

  • TBI significantly compromises proteostasis, contributing to accelerated brain aging.
  • Proteostatic decline following TBI may underlie long-term neurodegenerative changes.
  • Targeting proteostasis could offer therapeutic strategies for mitigating TBI's long-term consequences.

Related Concept Videos

Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
358
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
2.9K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
51
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
4.4K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
38
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
49